Convents A, Convents D, De Backer J P, De Keyser J, Vauquelin G
Department of Protein Chemistry, Vrije Universiteit Brussel, Belgium.
Biochem Pharmacol. 1989 Feb 1;38(3):455-63. doi: 10.1016/0006-2952(89)90385-7.
The radiolabeled antagonists 3H RX 781094 and 3H rauwolscine bind with high affinity to alpha 2 adrenergic receptors as well as to non-receptor sites in human and rabbit brain cortex membranes. These non-receptor sites form an important contaminant of the specific binding when non-specific binding is determined in the presence of 10 microM phentolamine or more. While phentolamine is no suitable ligand to discriminate both sites, (-)-epinephrine displays a sufficient affinity ratio to separate radioligand binding to these sites. When 1 microM (-)-epinephrine is used for the determination of the non-specific binding, both radioligands bind specifically to alpha 2 receptors. Under these conditions, 3H rauwolscine and 3H RX 781094 bind to the same amount of non-cooperative sites; binding isotherms for human brain are Bmax = 113 +/- 15 fmol/mg protein and Kd = 22.8 +/- 4.2 nM for 3H RX781094 and Bmax = 110 +/- 17 fmol/mg protein and Kd = 4.7 +/- 2.5 nM for 3H rauwolscine. Competition binding experiments show, for both radioligands and in both species, the typical pharmacological potency order of alpha 2 adrenergic receptors, i.e. phentolamine greater than yohimbine greater than prazosin for the antagonists and UK 14304 greater than p-aminoclonidine greater than or equal to (-)-epinephrine greater than (+)-epinephrine greater than isoproterenol for the agonists. Whereas the alpha 2 receptor sites display high affinity and stereoselectivity towards (-)-epinephrine and (+)-epinephrine, the non-receptor sites bind both epinephrine isomers with equal low affinity. Specific binding of both radioligands to these sites can be determined when total binding is performed in the presence of 1 microM (-)-epinephrine and non-specific binding the presence of 1 mM phentolamine. 3H rauwolscine binding to the non-stereoselective sites can be displaced with high affinity by 5-HT, suggesting binding to a 5-HT1-receptor. The 3H RX 781094 binding displays low affinity for most alpha adrenergic ligands and do not correspond to beta adrenergic, dopaminergic or serotonergic receptors.
放射性标记的拮抗剂3H RX 781094和3H萝芙木碱与人及兔脑皮质膜中的α2肾上腺素能受体以及非受体位点具有高亲和力结合。当在10微摩尔酚妥拉明或更高浓度存在下测定非特异性结合时,这些非受体位点构成特异性结合的重要污染物。虽然酚妥拉明不是区分这两个位点的合适配体,但(-)-肾上腺素显示出足够的亲和力比来分离放射性配体与这些位点的结合。当使用1微摩尔(-)-肾上腺素测定非特异性结合时,两种放射性配体都特异性地结合到α2受体上。在这些条件下,3H萝芙木碱和3H RX 781094结合到相同数量的非协同位点;人脑的结合等温线对于3H RX781094为Bmax = 113±15飞摩尔/毫克蛋白质,Kd = 22.8±4.2纳摩尔,对于3H萝芙木碱为Bmax = 110±17飞摩尔/毫克蛋白质,Kd = 4.7±2.5纳摩尔。竞争结合实验表明,对于两种放射性配体和两个物种,α2肾上腺素能受体具有典型的药理效力顺序,即对于拮抗剂,酚妥拉明>育亨宾>哌唑嗪,对于激动剂,UK 14304>对氨基可乐定≥(-)-肾上腺素>(+)-肾上腺素>异丙肾上腺素。虽然α2受体位点对(-)-肾上腺素和(+)-肾上腺素显示出高亲和力和立体选择性,但非受体位点以相等的低亲和力结合两种肾上腺素异构体。当在1微摩尔(-)-肾上腺素存在下进行总结合,在1毫摩尔酚妥拉明存在下进行非特异性结合时,可以测定两种放射性配体与这些位点的特异性结合。5-羟色胺可以高亲和力取代3H萝芙木碱与非立体选择性位点的结合,表明其与5-HT1受体结合。3H RX 781094结合对大多数α肾上腺素能配体显示出低亲和力,且与β肾上腺素能、多巴胺能或5-羟色胺能受体不符。